Диссертация (1335905), страница 27
Текст из файла (страница 27)
Transplant. – 2007. – Vol.22, №2. – P. 522-528.95.Komaba, H. Cinacalcet effectively reduces parathyroid hormone secretion andgland volume regardless of pretreatment gland size in patients with secondaryhyperparathyroidism / H. Komaba, S. Nakanishi, A.
Fujimori, M. Tanaka, J.Shin, K. Shibuya, M. Nishioka, H. Hasegawa, T. Kurosawa, M. Fukagawa //Clin J Am Soc Nephrol. – 2010. – Vol. 5(12). – P. 2305–2314.96.Kooienga, L. The effect of combined calcium and vitamin D3 supplementationon serum intact parathyroid hormone in moderate CKD / L. Kooienga, L. Fried,R. Scragg, J.
Kendrick, G. Smits, M. Chonchol // American Journal of KidneyDiseases. – 2009. – Vol.53. – P. 408-16.97.Kovesdy,C.P.Paricalcitolversusergocalciferolforsecondaryhyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial /C.P. Kovesdy, J.L. Lu, S.M. Malakauskas, D.L. Andress, K. Kalantar-Zadeh, S.Ahmadzadeh // American Journal of Kidney Diseases. – 2012. – Vol.59. – P.58-66.98.Krause, R. Vitamin D Status in Chronic Kidney Disease - UVB Irradiation IsSuperior to Oral Supplementation / R. Krause, H.J. Roth, H. Kaase, R.
Stange,M.F. Holick // Anticancer Res. – 2016. – Vol.36, №3. – P. 1397-401.99.Lacour, B. Chronic renal failure is associated with increased tissue depositionof lanthanum after 28-day oral administration /B. Lacour, A. Lucas, D.Auchère, N. Ruellan, N.M. de Serre Patey, T.B. Drüeke // Kidney Int. – 2005. –Vol.67. - P.1062–1069.100. Lafrance, J.P.
Effect of cinacalcet availability and formulary listing onparathyroidectomy rate trends/ J.P. Lafrance, H. Cardinal, M. Leblanc, F.Madore, V. Pichette, L. Roy, J. Le Lorier // BMC Nephrol. – 2013. - 14:100.101. Lin, H.C. Parathyroidectomy improves cardiovascular outcome innondiabetic dialysis patients with secondary hyperparathyroidism / H.C. Lin,C.L. Chen, H.S. Lin, K.J. Chou, H.C. Fang, S.I. Liu, C.Y. Hsu, W.C.
Huang,156C.W. Huang, C.K. Huang, T.Y. Chang, Y.T. Chang, P.T. Lee // ClinicalEndocrinology. – 2014. – Vol.80, №4. – P. 508–515.102. Lin, W.T. Tumoral calcinosis in renal failure / W.T. Lin, C.M. Chao / QJM– 2014. – Vol.107, №5. – P. 387.103. Lopes, A.A. Phosphate binder use and mortality among hemodialysispatients in the Dialysis Outcomes and Practice Patterns Study (DOPPS):evaluation of possible confounding by nutritional status / A.A. Lopes, L.
Tong,J. Thumma, Y. Li, D.S. Fuller, H. Morgenstern, J. Bommer, P.G. Kerr, F.Tentori, T. Akiba, B.W. Gillespie, B.M. Robinson, F.K. Port, R.L. Pisoni // AmJ Kidney Dis. – 2012. – Vol.60, №1. – P. 90-101.104. Lopez, I. The effect of calcitriol, paricalcitol, and a calcimimetic onextraosseous calcifications in uremic rats / I. Lopez, F.J. Mendoza, E. AguileraTejero, J. Perez, F. Guerrero, D. Martin, M. Rodriguez // Kidney Int. – 2008. –Vol.73, №3.
– P. 300-307.105. Lorenz, K. Total parathyroidectomy without autotransplantation for renalhyperparathyroidism: experience with a qPTH-controlled protocol / K. Lorenz,J. Ukkat, C. Sekulla, O. Gimm, M. Brauckhoff, H. Dralle // World J Surg. –2006. – Vol. 30, №5. – P. 743–751.106. Lynch, K.E. Prescribed dietary phosphate restriction and survival amonghemodialysis patients / K.E. Lynch, R. Lynch, G.C. Curhan, S.M.
Brunelli //Clin J Am Soc Nephrol. – 2011. – Vol.6, №3. – P. 620-9.107. Ma, T.L. Parathyroidectomy Is Associated with Reduced Mortality inHemodialysis Patients with Secondary Hyperparathyroidism / Ma TL, HungPH, Jong IC, Hiao CY, Hsu YH, Chiang PC, Guo HR, Hung KY. // Biomed.Res. Int. – 2015. - 639587.108. Maduell, F. High-efficiency postdilution online hemodiafiltration reducesall-cause mortality in hemodialysis patients / F Maduell, F. Moreso, M.
Pons,R. Ramos, J. Mora-Macià, J. Carreras, J. Soler, F. Torres, J.M. Campistol, A.Martinez-Castelao // JASN. – 2013. – Vol.24, №3. – P. 487–497.157109. Mann, M.C. Effect of oral vitamin D analogs on mortality andcardiovascular outcomes among adults with chronic kidney disease : a metaanalysis / M.C. Mann, A.J. Hobbs, B.R.
Hemmelgarn, D.J. Roberts, S.B.Ahmed, D.M. Rabi // Clin Kidney J. – 2015. – Vol.8, №1. – P. 41-8.110. Martin, K.J. Velcalcetide (AMG 416), a novel peptide agonist of thecalcium-sensing receptor, reduces serum parathyroid hormone and FGF23levels in healthy male subjects / K.J. Martin, G. Bell, K.
Pickthorn, S. Huang,A. Vick, P Hodsman, Peacock M // Nephrol Dial Transplant. – 2014. – Vol.29,№2 – P. 385–392.111. Massy, Z.A. Magnesium and outcomes in patients with chronic kidneydisease: focus on vascular calcification, atherosclerosis and survival / Z.A.Massy, T.B. Drueke // Clin Kidney J. – 2012. – Vol.5 (Suppl. 1). – P. 52–61.112. Meola, M.
Long-term treatment with cinacalcet and conventional therapyreduces parathyroid hyperplasia in severe secondary hyperparathyroidism / M.Meola, I. Petrucci, G. Barsotti // Nephrol Dial Transplant. – 2009. – Vol.24,№3. - P.982-9.113. Meola, M. Ultrasound in clinical setting of secondary hyperparathyroidism /M. Meola, I. Petrucci, A. Cupisti // J Nephrol.
– 2013. – Vol.26, №5. – P. 84855.114. Messa,P.TheOPTIMAstudy:assessinganewcinacalcet(Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism / P.Messa, F. Macário, M. Yaqoob, K. Bouman, J. Braun, B. von Albertini, H.Brink, F. Maduell, H. Graf, J.M. Frazão, W.J. Bos, V. Torregrosa, H. Saha, H.Reichel, M. Wilkie, V.J. Zani, B. Molemans, D. Carter, F. Locatelli // Clin JAm Soc Nephrol. – 2008 - Vol.3, №1. – P.
36-45.115. Mieczkowski, M. Long-term cholecalciferol administration in hemodialysispatients: a single-center randomized pilot study / M. Mieczkowski, P.Żebrowski, E. Wojtaszek, T. Stompór, J. Przedlacki, Z. Bartoszewicz, J.Sierdziński, Z. Wańkowicz, S. Niemczyk, J. Matuszkiewicz-Rowińska // MedSci Monit. – 2014.
– Vol.20. – P. 2228-34.158116. Miller, G. Cinacalcet HCl prevents development of parathyroid glandhyperplasia and reverses established parathyroid gland hyperplasia in a rodentmodel of CKD / Gerald Miller, James Davis, Edward Shatzen, MatthewColloton, David Martin, Charles M. Henley // Nephrol Dial Transplant. – 2012.- Vol.27, №6. – P.
2198–2205.117. Minutolo, R. Postdialytic rebound of serum phosphorus: pathogenetic andclinical insights /R. Minutolo, V. Bellizzi, M. Cioffi, C. Iodice, P.Giannattasio, M. Andreucci, V. Terracciano, B.R. Di Iorio, G. Conte, L. DeNicola // JASN. – 2002. – Vol.13, №4. – P. 1046–1054.118. Miskulin, D.C.
Ergocalciferol Supplementation in Hemodialysis PatientsWith Vitamin D Deficiency: A Randomized Clinical Trial / D.C. Miskulin, K.Majchrzak, H. Tighiouart, R.S. Muther, T. Kapoian, D.S. Johnson, D.E. Weiner// J Am Soc Nephrol. – 2016. – Vol.27, №6. – P. 1801-10.119. Mizobuchi, M. Differential effects if vitamin D receptor activators onvascular calcification in uremic rats / M. Mizobuchi, J.L.
Finch, D.R. Martin, E.Slatopolsky // Kidney Int. – 2007. – Vol.72. – P. 709-715.120. Moe, S.M. Achieving NKF-K/DOQI bone metabolism and disease treatmentgoals with cinacalcet HCl / S.M. Moe, G.M. Chertow, J.W. Coburn, L.D.Quarles, W.G. Goodman, G.A. Block, T.B. Drüeke, J. Cunningham, D.J.Sherrard, L.C. McCary, K.A. Olson, S.A.
Turner, K.J. Martin // Kidney Int. –2005. – Vol.67, №2. – P. 760-771.121. Moe, S.M. Effects of Cinacalcet on Fracture Events in Patients ReceivingHemodialysis: The EVOLVE Trial / S.M. Moe, S. Abdalla, G.M. Chertow, P.S.Parfrey, G.A. Block, R. Correa-Rotter, J. Floege, C.A. Herzog, G.M. London,K.W. Mahaffey, D.C. Wheeler, B.
Dehmel, W.G. Goodman, T.B. Drüeke // JAm Soc Nephrol. – 2015. – Vol.26, №6. – P. 1466-75.122. Nakai, K. Parathyroid enlargement at dialysis initiation in patients withchronic kidney diseases / K. Nakai, H. Fujii, K. Kono, S. Goto, S. Miura, A.Maeda, K. Takeda, S. Nishi // Ther Apher Dial. – 2013. – Vol.17, №1. – P. 249.159123.
Nakamura, M. Effects of percutaneous ethanol injection therapy onsubsequent surgical parathyroidectomy / M. Nakamura, Y. Marui, Y. Ubara, S.Nakanishi, F. Takemoto, K. Takaichi, S. Tomikawa // NDT Plus. – 2008. –Vol.1 (Suppl. 3) – P. 39-41.124. National Kidney Foundation. K/DOQI clinical practice guidelines for bonemetabolism and disease in chronic kidney disease // Am.
J. Kidney Dis. – 2003- Vol.42 (Suppl. 3). –P.1-201.125. Nemeth, E.F. Pharmacological regulation of parathyroid hormone secretion /E.F. Nemeth // Curr Pharm Des. – 2002. – Vol.8 – P. 2077-2087.126. Noori, N. Association of dietary phosphorus intake and phosphorus toprotein ratio with mortality in hemodialysis patients / N. Noori, K. KalantarZadeh, C.P. Kovesdy, R. Bross, D. Benner, J.D. Kopple // Clin J Am SocNephrol. – 2010. – Vol.5, №4. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
